A federal judge revived a lawsuit challenging access to the abortion drug mifepristone just days before the 52nd anniversary of the landmark Roe v. Wade decision.
After the Supreme Court overturned Roe in 2022, anti-abortion advocates launched a barrage of litigation, including a federal suit in Texas aimed at mifepristone, one drug in a two-drug regimen used in medication abortions.